Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, B-Cell, Marginal Zone

Explore clinical trials studying Lymphoma, B-Cell, Marginal Zone. Study availability and eligibility vary by location and protocol.

646 public trials 88 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, B-Cell, Marginal Zone trial results

Completed

Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder

NCT00755040

Conditions
Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +62 more
Locations
  • Stanford University Palo Alto, California, United States
  • Norwestern Memorial Hospital Chicago, Illinois, United States
  • Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
  • M. D. Anderson Cancer Center Houston, Texas, United States
View Trial Details
Completed

American Ginseng in Treating Patients With Fatigue Caused by Cancer

NCT00719563

Conditions
Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +103 more
Locations
  • Mayo Clinic Scottsdale Scottsdale, Arizona, United States
  • Aurora Presbyterian Hospital Aurora, Colorado, United States
  • Boulder Community Hospital Boulder, Colorado, United States
  • Penrose Cancer Center at Penrose Hospital Colorado Springs, Colorado, United States
View all 326 locations
View Trial Details
Completed

Fludarabine Plus Octreotide in Treating Patients With Relapsed Low-Grade Non-Hodgkin's Lymphoma

NCT00002779

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +27 more
Locations
  • CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States
  • CCOP - Illinois Oncology Research Association Peoria, Illinois, United States
  • CCOP - Carle Cancer Center Urbana, Illinois, United States
  • CCOP - Cedar Rapids Oncology Project Cedar Rapids, Iowa, United States
View all 20 locations
View Trial Details
Completed

Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer

NCT00053053

Conditions
Body Weight, Body Weight Changes, Burkitt Lymphoma, +44 more
Locations
  • Comprehensive Cancer Center at University of Alabama at Birmingham Birmingham, Alabama, United States
  • Comprehensive Cancer Institute Huntsville, Alabama, United States
  • MBCCOP - Gulf Coast Mobile, Alabama, United States
  • Montgomery Cancer Center Montgomery, Alabama, United States
View all 250 locations
View Trial Details
Completed

Combination Chemotherapy Plus Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma

NCT00005601

Conditions
Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +29 more
Locations
  • CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • CCOP - Illinois Oncology Research Association Peoria, Illinois, United States
  • CCOP - Cedar Rapids Oncology Project Cedar Rapids, Iowa, United States
View all 21 locations
View Trial Details

Related conditions